Hepln-13
Product Specifications
Product Name Alternative
Clodantoin,Xenazoic acid; CV58913
UNSPSC Description
Hepln-13 is a potent and orally active Hepsin inhibitor with an IC50 of 0.33 μM. Hepln-13 can be used for the research of metastatic prostate cancer[1].
Target Antigen
Ser/Thr Protease
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hepln-13.html
Purity
99.34
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
BrC1=CC=C(C=C1)C(N2)NC3=C4C2=CC=CC4=CC=C3
Molecular Weight
325.20
References & Citations
[1]Tang X, et al. Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget. 2014;5(5):1352-1362.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-118134/Hepln-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-118134/Hepln-13-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
64369-13-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP42211_T100-FITC 100 µL
RAD23A Antibody - middle region: FITC (ARP42211_T100-FITC)
Ask
View Details 